COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW
Envoy Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.65−0.01 (-2.10%)
Close on Oct 19, 2026
- Market cap
- $68.04M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.1848 (−22.03%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Envoy Medical, Inc. saw revenue fall 6.8% to $207.00K over the twelve months to Jun 30, 2026. Free cash flow was -$18.38M.
Revenue
$207.00K
-6.8% vs. a year earlier
Operating income
-$23.62M
TTM Q2 2026
Free cash flow
-$18.38M
FY2025
EPS, diluted
-$0.77
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $68.04M
- P/E ratio
- –
- Price to sales
- 328.70
- Price to book
- 20.60
- Dividend yield
- –
- Free cash flow yield
- -27.01%
Fundamentals
- Revenue
- $207.00K
- Net income
- -$23.40M
- EPS, diluted
- -$0.77
- Free cash flow
- -$18.38M
- Book value per share
- $0.03
- Diluted shares
- 104M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$207.00K-6.8% YoY
Gross profit
-$798.00K
Operating income
-$23.62M
Net income
-$23.40M
EPS, diluted
-$0.77
Free cash flow
–
Reported periodTrailing twelve months